BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16686775)

  • 21. Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.
    Snell GI; Levvey BJ; Zheng L; Bailey M; Orsida B; Williams TJ; Kotsimbos TC
    J Heart Lung Transplant; 2007 Jul; 26(7):669-74. PubMed ID: 17613395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed analysis of cell profiles in peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and CMV infection in lung and heart-lung allograft recipients.
    Tikkanen J; Lemström K; Halme M; Pakkala S; Taskinen E; Koskinen P
    Transplant Proc; 1999; 31(1-2):163-4. PubMed ID: 10083058
    [No Abstract]   [Full Text] [Related]  

  • 23. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
    Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplant Proc; 2009 Mar; 41(2):595-8. PubMed ID: 19328934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of C4d as a diagnostic adjunct in lung allograft biopsies.
    Magro CM; Pope Harman A; Klinger D; Orosz C; Adams P; Waldman J; Knight D; Kelsey M; Ross P
    Am J Transplant; 2003 Sep; 3(9):1143-54. PubMed ID: 12919095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broncho-alveolar lavage fluid recovery correlates with airway neutrophilia in lung transplant patients.
    Vanaudenaerde BM; Wuyts WA; Geudens N; Nawrot TS; Vos R; Dupont LJ; Van Raemdonck DE; Verleden GM
    Respir Med; 2008 Mar; 102(3):339-47. PubMed ID: 18086521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decline in 25% to 75% forced expiratory flow as an early predictor of chronic airway rejection in pediatric lung transplant recipients.
    Rosen JB; Smith EO; Schecter MG; Mallory GB; Elidemir O
    J Heart Lung Transplant; 2012 Dec; 31(12):1288-92. PubMed ID: 23102913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary rejection diagnosis after lung and heart-lung transplantation.
    Reichenspurner H; Dienemann H; Rihl M; Wagner F; Meiser BM; Kur F; Hammer C; Forst H; Kreuzer E; Reichart B
    Transplant Proc; 1993 Dec; 25(6):3299-300. PubMed ID: 8266550
    [No Abstract]   [Full Text] [Related]  

  • 32. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors.
    De Vleeschauwer SI; Wauters S; Dupont LJ; Verleden SE; Willems-Widyastuti A; Vanaudenaerde BM; Verleden GM; Van Raemdonck DE
    J Heart Lung Transplant; 2011 Sep; 30(9):975-81. PubMed ID: 21665490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
    Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
    J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
    Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation.
    Zheng L; Orsida B; Whitford H; Levvey B; Ward C; Walters EH; Williams TJ; Snell GI
    Transplantation; 2005 Jul; 80(2):185-92. PubMed ID: 16041262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin.
    Mertens V; Blondeau K; Van Oudenhove L; Vanaudenaerde B; Vos R; Farre R; Pauwels A; Verleden G; Van Raemdonck D; Sifrim D; Dupont LJ
    Am J Transplant; 2011 Feb; 11(2):329-35. PubMed ID: 21272237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
    Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD; Galbán CJ; Vanaudenaerde BM
    Am J Transplant; 2016 Nov; 16(11):3262-3269. PubMed ID: 27367568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchiolitis obliterans syndrome after heart-lung transplantation: a case report and review of literature.
    Sittpunt C; Wongtim S; Udompanich V; Kaewkittinarong K; Luengtaviboon K
    J Med Assoc Thai; 2004 Jun; 87(6):713-6. PubMed ID: 15279355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.